Upgrade to SI Premium - Free Trial

Bicycle Therapeutics (BCYC) PT Raised to $40 at Canaccord Genuity

July 15, 2021 7:58 AM
Canaccord Genuity analyst Arlinda Lee raised the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $40.00 (from $36.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Analyst Comments Analyst PT Change

Next Articles